These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37181899)

  • 21. Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder.
    Rosoff DB; Charlet K; Jung J; Lee J; Muench C; Luo A; Longley M; Lohoff FW
    Alcohol; 2020 Aug; 86():93-101. PubMed ID: 32335269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol use disorder and alcohol withdrawal syndrome in Vietnamese hospitalized patients.
    Mai Loan NT; Bertino JS; Kittisopee T
    Alcohol; 2019 Aug; 78():51-56. PubMed ID: 30660599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of phenobarbital for prevention of alcohol withdrawal in trauma patients.
    Kip LM; Forni A; Dorfman JD; Li I
    J Trauma Acute Care Surg; 2023 Oct; 95(4):573-576. PubMed ID: 37418690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.
    Brotherton AL; Hamilton EP; Kloss HG; Hammond DA
    Pharmacotherapy; 2016 Apr; 36(4):433-42. PubMed ID: 26893017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketamine Treatment for Alcohol Use Disorder: A Systematic Review.
    Kelson M; Burnett JM; Matthews A; Juneja T
    Cureus; 2023 May; 15(5):e38498. PubMed ID: 37273364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome.
    Nishimura Y; Choi H; Colgan B; Kistler H; Mercado F
    Eur J Intern Med; 2023 Jun; 112():52-61. PubMed ID: 36935249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delirium tremens in an AUD patient after an intrathecal baclofen pump induced total alcohol abstinence.
    Calvo ME; Gunnarsson T; Smith L; Hao M
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5371-5376. PubMed ID: 30178864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease.
    Chand PK; Panda U; Mahadevan J; Murthy P
    J Clin Exp Hepatol; 2022; 12(6):1527-1534. PubMed ID: 36340306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
    Kwan ATH; Rosenblat JD; Mansur RB; Teopiz KM; McIntyre RS
    J Affect Disord; 2024 Sep; 360():421-426. PubMed ID: 38795777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural Mechanisms Underlying the Rewarding and Therapeutic Effects of Ketamine as a Treatment for Alcohol Use Disorder.
    Strong CE; Kabbaj M
    Front Behav Neurosci; 2020; 14():593860. PubMed ID: 33362485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Gabapentin and Baclofen Combination for Inpatient Management of Alcohol Withdrawal Syndrome.
    Karapetyan K; Rosenfeldt Z; Caniff K
    Fed Pract; 2023 Apr; 40(4):128-133. PubMed ID: 37223663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Anticonvulsant Adjuncts to Treat Alcohol Withdrawal Syndrome in Older Adults.
    Montgomery S; Dahri K; Rayani K; Kwok J; Chan P
    Can Geriatr J; 2022 Mar; 25(1):32-39. PubMed ID: 35310475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gabapentin for Alcohol-Related Disorders: Critical Appraisal of the Symptom-Driven Approach.
    Andrade C
    J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33238082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials.
    Ungur LA; Neuner B; John S; Wernecke K; Spies C
    Alcohol Clin Exp Res; 2013 Apr; 37(4):675-86. PubMed ID: 23550610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of pharmacological approaches in the treatment of alcohol withdrawal syndrome (AWS): a literature review.
    Cooper E; Vernon J
    J Psychiatr Ment Health Nurs; 2013 Sep; 20(7):601-12. PubMed ID: 22989012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges.
    Farrokh S; Roels C; Owusu KA; Nelson SE; Cook AM
    Neurocrit Care; 2021 Apr; 34(2):593-607. PubMed ID: 32794143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation.
    Shah P; McDowell M; Ebisu R; Hanif T; Toerne T
    J Med Toxicol; 2018 Sep; 14(3):229-236. PubMed ID: 29748926
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.